EUVIMEDEUVIMED entdecken
Crossref

Nano-immunotherapy combining PD-L1 blockade with Ca2+-mediated immune activation

Ying Wang, Wanying Xiong, Yiyan Xu, Nan Yang, Huige Zheng, Qian Zhao, Xiaojing Liang, Huishuang Yin, Yunyan Zhang, Wenhu Zhou, Liangsheng Fan

Chemical Engineering Journal · 2026-07 · 540 · 177487

DOI: 10.1016/j.cej.2026.177487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-07. Verfasst von Ying Wang und 10 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Xiong, W., Xu, Y., Yang, N., Zheng, H., Zhao, Q., Liang, X., Yin, H., Zhang, Y., Zhou, W., & Fan, L. (2026). Nano-immunotherapy combining PD-L1 blockade with Ca2+-mediated immune activation. Chemical Engineering Journal, 540, 177487. https://doi.org/10.1016/j.cej.2026.177487

Vancouver

Wang Y, Xiong W, Xu Y, Yang N, Zheng H, Zhao Q, et al. Nano-immunotherapy combining PD-L1 blockade with Ca2+-mediated immune activation. Chemical Engineering Journal. 2026;540:177487. doi:10.1016/j.cej.2026.177487

BibTeX
@article{Wang2026,
  author = {Wang, Ying and Xiong, Wanying and Xu, Yiyan and Yang, Nan and Zheng, Huige and Zhao, Qian and Liang, Xiaojing and Yin, Huishuang and Zhang, Yunyan and Zhou, Wenhu and Fan, Liangsheng},
  title = {Nano-immunotherapy combining PD-L1 blockade with Ca2+-mediated immune activation},
  journal = {Chemical Engineering Journal},
  year = {2026},
  volume = {540},
  pages = {177487},
  doi = {10.1016/j.cej.2026.177487}
}
Kostenlos starten →